NEWFlashcards for any set of questions, quick-reference tables for breast, lung and prostate, and a month of access for every colleague you refer. See what changed

Breast: Whole-breast hypofractionation

Free question published 19 July 2026

BreastWhole-breast hypofractionation (FAST-Forward)

A 58-year-old woman has undergone wide local excision for a 14 mm, grade 2, ER-positive, HER2-negative invasive ductal carcinoma. The sentinel node biopsy was negative (pN0) and resection margins are clear. She is to receive adjuvant whole-breast radiotherapy without regional nodal irradiation, and you are discussing fractionation. Which schedule is the most appropriate standard whole-breast schedule to offer?

  1. A60 Gy in 30 fractions over 6 weeks
  2. B40 Gy in 15 fractions over 3 weeks
  3. C50 Gy in 25 fractions over 5 weeks
  4. D50 Gy in 25 fractions plus a 16 Gy boost
  5. E26 Gy in 5 fractions over 1 week

Why E is correct

Since 2023 NICE NG101 recommends offering 26 Gy in 5 fractions over 1 week for whole-breast radiotherapy without regional lymph node irradiation after breast-conserving surgery. This follows FAST-Forward, in which 26 Gy in 5 fractions over 1 week was non-inferior to 40 Gy in 15 fractions over 3 weeks for ipsilateral breast tumour relapse (5-year 1.4% versus 2.1%) with similar normal tissue effects. 40 Gy in 15 fractions, established by START B, remains a schedule NICE says to consider for people with a diagnosis that increases sensitivity to radiotherapy, implant-based reconstruction, or another reason to prefer three weeks.

And why the others are not

  • AIncorrect. 60 Gy in 30 fractions overtreats the whole breast and is not an adjuvant whole-breast schedule.
  • BIncorrect as the standard. 40 Gy in 15 fractions over 3 weeks is the START B schedule; NICE now lists it as a schedule to consider in specific circumstances such as increased radiotherapy sensitivity or implant-based reconstruction, none of which applies here.
  • CIncorrect. 50 Gy in 25 fractions is the historical conventional schedule that hypofractionation has replaced.
  • DIncorrect. A tumour-bed boost is for those at high risk of local recurrence; this node-negative grade 2 patient does not warrant one, and the 50 Gy base is outdated.

Source NICE NG101 — Early and locally advanced breast cancer: radiotherapy recommendations — National Institute for Health and Care Excellence. Early and locally advanced breast cancer: diagnosis and management. NICE guideline NG101. Published 18 July 2018, last updated 14 April 2025.

More free breast questions

Sitting in February? Follow the twenty-week plan.

2,500+ cited questions like this one are waiting in the vault.

See plans and pricing